172 related articles for article (PubMed ID: 37413774)
1. Plasma exosomal microRNAs are non-invasive biomarkers of moyamoya disease: A pilot study.
Huang D; Qi H; Yang H; Chen M
Clinics (Sao Paulo); 2023; 78():100247. PubMed ID: 37413774
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.
Kang K; Shen Y; Zhang Q; Lu J; Ju Y; Ji R; Li N; Wu J; Yang B; Lin J; Liang X; Zhang D; Zhao X
Front Genet; 2022; 13():816919. PubMed ID: 35669195
[No Abstract] [Full Text] [Related]
3. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
[TBL] [Abstract][Full Text] [Related]
4. Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study.
Zhang D; Zhao X; Wang B; Liu X; Aizezi A; Ma X
Medicine (Baltimore); 2023 Jul; 102(30):e34474. PubMed ID: 37505131
[TBL] [Abstract][Full Text] [Related]
5. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.
Han LL; Wang SH; Yao MY; Zhou H
World J Diabetes; 2024 Jan; 15(1):92-104. PubMed ID: 38313849
[TBL] [Abstract][Full Text] [Related]
6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z
Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
[TBL] [Abstract][Full Text] [Related]
9. Serum miRNA signature in Moyamoya disease.
Dai D; Lu Q; Huang Q; Yang P; Hong B; Xu Y; Zhao W; Liu J; Li Q
PLoS One; 2014; 9(8):e102382. PubMed ID: 25093848
[TBL] [Abstract][Full Text] [Related]
10. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
11. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
[TBL] [Abstract][Full Text] [Related]
12. Construction and Comprehensive Analysis of Dysregulated Long Noncoding RNA-Associated Competing Endogenous RNA Network in Moyamoya Disease.
Gu X; Jiang D; Yang Y; Zhang P; Wan G; Gu W; Shi J; Jiang L; Chen B; Zheng Y; Liu D; Guo S; Lu C
Comput Math Methods Med; 2020; 2020():2018214. PubMed ID: 32617116
[TBL] [Abstract][Full Text] [Related]
13. A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease.
Wang G; Wen Y; Faleti OD; Zhao Q; Liu J; Zhang G; Li M; Qi S; Feng W; Lyu X
Front Neurosci; 2020; 14():548278. PubMed ID: 33100957
[TBL] [Abstract][Full Text] [Related]
14. Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease.
Wang G; Wen Y; Chen S; Zhang G; Li M; Zhang S; Qi S; Feng W
CNS Neurosci Ther; 2021 Aug; 27(8):908-918. PubMed ID: 33942536
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
[TBL] [Abstract][Full Text] [Related]
16. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.
Zhang L; Li H; Yuan M; Li D; Sun C; Wang G
Dis Markers; 2020; 2020():2456340. PubMed ID: 32076458
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum exosomal miR-98-5p, miR-183-5p, miR-323-3p and miR-19b-3p as potential biomarkers for glioblastoma patients and investigation of their mechanisms.
Yang Q; Wei B; Peng C; Wang L; Li C
Curr Res Transl Med; 2022 Jan; 70(1):103315. PubMed ID: 34837760
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
Chen X; Huang F; Liu Y; Liu S; Tan G
Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
[TBL] [Abstract][Full Text] [Related]
19. Plasma-derived exosomal let-7c-5p, miR-335-3p, and miR-652-3p as potential diagnostic biomarkers for stable coronary artery disease.
Han J; Cui X; Yuan T; Yang Z; Liu Y; Ren Y; Wu C; Bian Y
Front Physiol; 2023; 14():1161612. PubMed ID: 37228823
[No Abstract] [Full Text] [Related]
20. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
